Archive for July, 2018

22% Bb Antibodies in Polish Forest Workers

https://www.ncbi.nlm.nih.gov/m/pubmed/29963907/

Seroprevalence of Borrelia burgdorferi in forest workers from inspectorates with different forest types in Lower Silesia, SW Poland: preliminary study.

Kiewra D, et al. Int J Environ Health Res. 2018.

Abstract

To estimate the Lyme borreliosis (LB) risk for forest workers, totally 646 blood samples were tested for IgG and IgM anti-Borrelia burgdorferi s.l. (anti-B.b.) antibody occurrence using ELISA tests confirmed with western blot. To clarify the varied LB risk, additionally, the data from the Forest Data Bank determining the detailed forest habitat type in particular forest inspectorates were used. The occurrence of the anti-B.b. antibody was confirmed in 22% (8.7% IgM, 17.8% IgG) of forest workers. Analysis of the influence of the habitat type (forest types) indicated the significant positive impact of the occurrence of the deciduous and mixed-deciduous forests on the seroprevalence of anti-B.b. IgG level among forestry workers. However, the share of forest type cannot be the only factor taken into account when assessing risk.

________________

**Comment**

IgM is the first antibody that the body produces in an acute infection or recent exposure. IgG refers to a later response.  These forest workers had more antibodies relating to older exposure.  It also makes sense that there would be a significant impact in deciduous and mixed-deciduous forests on seroprevalence.

For more on Bb in Poland:  https://madisonarealymesupportgroup.com/2018/04/06/prevalence-of-bb-in-poland/  The results of the study clearly show that ticks infected with Borrelia burgdorferi inhabit all regions of Poland. The results are consistent with National Institute of Hygiene data which indicates that Lyme disease cases are recorded in all regions of Poland.

More on forest workers:  https://madisonarealymesupportgroup.com/2018/05/27/seroprevalence-of-bb-in-belgian-forestry-workers-assoc-risk-factors/  Sixty-seven of the 310 workers were seropositive for Lyme disease (LD), leading to a seroprevalence of 21.6%. The seroprevalence was higher among forest workers visiting forests more frequently (P = 0.003) or who reported over 100 tick bites (P-value < 0.001). The intensity of tick bites and the use of protection measures against tick bites have a positive impact on LD seroprevalence while the quantity of shadow from trees at ground level had a negative one.  This study showed that forest workers are a population at risk for LD and, by extension, at risk for various tick-borne diseases. I

 

Category:

Lyme, research, Testing

Parinaud’s Oculoglandular Syndrome & Bartonella

https://www.ncbi.nlm.nih.gov/m/pubmed/29982178/

Atypical presentation of cat scratch disease: Parinaud’s oculoglandular syndrome with facial nerve paresis.

Valor C, et al. BMJ Case Rep. 2018.

Abstract

A 28-year-old man presented to our clinic over the course of 3 weeks with symptoms that progressed from mild headaches to fever, fatigue, myalgia and an enlarged right preauricular lymph node with ipsilateral (same side) conjunctivitis and upper eyelid weakness. Our differential included Epstein Barr Virus/Cytomegalovirus mononucleosis, bacterial conjunctivitis and lymphoma. We evaluated with CBC, EBV IgM Ab, lactate dehydrogenase level and a CMV IgG Ab which were all within normal limits. During his third visit, we discovered our patient had been scratched by two stray kittens he had adopted 2 months prior. We confirmed the diagnosis with a positive Bartonella henselae IgG level and diagnosed him with cat scratch disease presenting as Parinaud’s oculoglandular syndrome. He was treated with a 5-day course of Azithromycin 250 mg with definitive improvement.

________________

**Comment**

The pre auricular lymph node is #5 in the diagram.  So this is a swollen nodule in front of the ear with conjunctivitis (pink-eye) on the same side as the nodule with upper eye-lid weakness.    

 

Illu_lymph_chain01

Public Domain, https://commons.wikimedia.org/w/index.php?curid=1471974

I would also like to point out it’s on record that people can have Bart without cat-scratch:  https://madisonarealymesupportgroup.com/2018/07/10/bartonella-henselae-neuroretinitis-in-patients-without-cat-scratch/  In conclusion, even though there may be a lack of systemic signs and symptoms of CSD in a patient with neuroretinitis, B henselae infection should be considered. 

While authorities argue about whether ticks transmit Bart or not, please see:  https://www.sciencedirect.com/topics/medicine-and-dentistry/parinauds-oculoglandular-syndrome  Finally, tick-borne B. henselae infection has been described, including scalp eschar and neck lymphadenopathy after tick bites in three patients during the colder months in France. B. henselae was detected using molecular tools both in skin biopsy (cervical and occipital) and in a Dermacentor marginatus tick removed from the scalp of one patient. All three patients had asthenia (weakness), but none had alopecia.

That same Science Direct link above also states that a common ocular manifestation is Parinaud’s oculoglandular syndrome……

I predict we are going to see a lot more on Bartonella in the future and it’s going to blow this whole “atypical” and “rare” thing out of the water.

For more on Bart:  https://madisonarealymesupportgroup.com/2016/01/03/bartonella-treatment/

https://madisonarealymesupportgroup.com/2018/06/12/osteomyelitis-in-cat-scratch-disease-a-never-ending-dilemma-a-case-report-literature-review/

https://madisonarealymesupportgroup.com/2018/05/07/fox-news-bartonella-is-the-new-lyme-disease/

https://madisonarealymesupportgroup.com/2016/08/09/a-bartonella-story/

https://madisonarealymesupportgroup.com/2017/09/13/dr-fox-cat-scratch-fever-warning/

 

 

Category:

Bartonella, research, Treatment

Learn About Advanced Cell Training – FREE – July 23

https://advancedcelltraining.com/live-call-advancedcelltraining/?utm_source=facebook&utm_medium=cpc&utm_campaign=liveq%26a&utm_term=061418

Tired of Dealing With Chronic Symptoms?

There is a new method (ACT) to help you heal from chronic symptoms, which uses your body’s ability to heal itself.  After attending the Live Q&A call, you’ll understand more.

When?  Monday, July 23 7 PM Eastern/4pm Pacific
  • Lyme
  • Back/Neck/Hip/ Joint pain
  • Depression/Anxiety/Emotional issues
  • Headaches, brain fog, dizziness
  • Allergies
  • Hair loss
  • Blurry vision
  • Leaky gut/constipation/diarrhea
  • Fatigue
  • much more

 

Get answers to your symptom-specific questions.

Call 401-398-7323 or click the button below to reserve your spot in our next Live Q&A Call. Learn how a home-based program trains your body to heal and ask ACT’s founder your questions–this call could be the best thing you do for your health!

Have questions or want to reserve your spot by phone? Call 401-398-7323 or click here if you want someone to contact you.

_________________

**Comment**

Please remember that Lyme/MSIDS is infectious and many of the symptoms are from either the active infection or the immune system’s response to the infection or dead debris.

If you are actively infected, you need antimicrobials.  ALL of my symptoms have been related to an active infection that antimicrobials took care of.  Of course we are all different but I can’t emphasize the importance of good antimicrobial treatment.  BTW:  treatment is often in the YEARS, not months or days.  

For an example of good treatment:  https://madisonarealymesupportgroup.com/2016/02/13/lyme-disease-treatment/

There is a video in the link at the top of the article of Jane Barrows, founder of Newport Rhode Island Lyme Support Group sharing how she recovered with ACT.  Other narratives include arthritis, chronic fatigue, and Anxiety/panic attacks.

It’s very true that Lyme/MSIDS is one of the most complex illnesses known to man and is hardly straight forward.  Much depends upon what you are infected with and how your immune system handles it.  For many there is a cognitive/psychological component that should never be underestimated.  I present information such as ACT in the hopes that some will be helped.  It may not work for you, however.  Do your own homework.  And as always, please discuss all treatments with your medical practitioner.

Category:

Activism, Treatment

HHS Vaccine Fraud Proven

  Real News With David Knight  Approx. 20 Min

Published July 13, 2018

Del Big Tree explains on “Real News With David Knight”  that in exchange for giving vaccine companies immunity from prosecution for adverse reaction & medical harm, the Federal government said it would take measures to monitor & improve vaccine safety. A new lawsuit by Del Bigtree shows HHS never looked at ANY safety or adverse reactions for ANY vaccine for the 31 years since they were given oversight.

Big Tree has this fact in bright purple crayon on a legal document.  This isn’t speculation.  This is fact.

For the proof:  http://icandecide.org/government/ICAN-HHS-Stipulated-Order-July-2018.pdf

Excerpt:

Whereas, on June 27, 2018, HHS sent ICAN the following response to the FOIA Request:

The [Department]’s searches for records did not locate any records responsive to your request.  The Department of Health and Human Services (HHS) Immediate Office of the Secretary (IOS) conducted a thorough search of its document tracking systems.  The Department also conducted a comprehensive review of all relevant indexes of HHS Secretarial Correspondence records maintained at Federal Records Centers that remain in the custody of HHS.  These searches did not locate records responsive to your request, or indications that records responsive to your request and in the custody of HHS are located at Federal Records Centers.  

Time to get rid of the 1986 Act 

(The 1986 Act grants economic immunity to pharmaceutical companies for injuries caused by vaccines.  (42 U.S.C. 300a a-11.)  It also makes HHS directly responsible for nearly every aspect of vaccine safety.  (42 U.S.C. 300a a-2, 300a a-27.) 

And we think HHS isn’t going to solve the Lyme/MSIDS problem?

https://madisonarealymesupportgroup.com/2018/07/18/hhs-not-to-be-trusted-with-lyme/

Go to icandecide.org for more info.

For more:  https://madisonarealymesupportgroup.com/2018/06/21/u-s-government-continues-to-pay-millions-in-vaccine-injuries-death-settlements/

https://madisonarealymesupportgroup.com/2018/03/21/congress-receives-vaccine-safety-project-details-since-the-cdc-fda-ignore-their-own-data-and-proclaim-vaccines-do-not-cause-autism/

https://madisonarealymesupportgroup.com/2018/07/10/pediatricians-state-new-who-aefi-guidelines-put-childrens-lives-at-risk-200-evidence-based-reasons-not-to-vaccinate/

https://madisonarealymesupportgroup.com/2017/09/19/autism-aluminum-adjuvant-link-corroborated/

https://madisonarealymesupportgroup.com/2018/06/01/immunoexcitotoxicity-as-the-central-mechanism-of-etiopathology-treatment-of-autism-spectrum-disorders-a-possible-role-of-fluoride-aluminum/

https://madisonarealymesupportgroup.com/2018/06/15/canadian-data-more-autism-where-vaccine-coverage-is-highest/

https://madisonarealymesupportgroup.com/2016/12/08/mercury-and-autism/

 

Category:

Activism, Lyme, Lyme Vaccine, vaccines

Study Finds 27 New Sequence Types of Borreliella afzelii – 2 Significant For EM’s Whereas Another Significant For Neuroborreliosis

https://www.ncbi.nlm.nih.gov/m/pubmed/29954419/

Multilocus sequence typing of clinical Borreliella afzelii strains: population structure and differential ability to disseminate in humans.

Gallais F, et al.
Parasit Vectors. 2018 Jun 28;11(1):374. doi: 10.1186/s13071-018-2938-x.

Abstract

BACKGROUND: Lyme borreliosis in humans results in a range of clinical manifestations, thought to be partly due to differences in the pathogenicity of the infecting strain. This study compared European human clinical strains of Borreliella afzelii (previously named Borrelia afzelii) using multilocus sequence typing (MLST) to determine their spatial distribution across Europe and to establish whether there are associations between B. afzelii genotypes and specific clinical manifestations of Lyme borreliosis. For this purpose, typing was performed on 63 strains, and data on a further 245 strains were accessed from the literature.

RESULTS: All 308 strains were categorized into 149 sequence types (STs), 27 of which are described here for the first time. Phylogenetic and goeBURST analyses showed short evolutionary distances between strains. Although the main STs differed among the countries with the largest number of strains of interest (Germany, the Netherlands, France and Slovenia), the B. afzelii clinical strains were less genetically structured than those previously observed in the European tick population. Two STs were found significantly more frequently in strains associated with clinical manifestations involving erythema migrans, whereas another ST was found significantly more frequently in strains associated with disseminated manifestations, especially neuroborreliosis.

CONCLUSIONS: The MLST profiles showed low genetic differentiation between B. afzelii strains isolated from patients with Lyme borreliosis in Europe. Also, clinical data analysis suggests the existence of lineages with differential dissemination properties in humans.

 

 

 

 

 

 

 

Category:

Lyme, research, Testing, Ticks